Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
288.20    -3.80 (-1.30%)
Bid:
289.40
Ask:
290.00
Spread: 0.60 (0.207%)
Market Cap: £1.00b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Director/PDMR Shareholding

26 Nov 2025 17:20

RNS Number : 1649J
Breedon Group PLC
26 November 2025
 

 

 

LEI: 213800DQGNQE3X76WS92

26 November 2025

 

BREEDON GROUP plc

(the Company)

 

Notification of transactions by Directors/Persons Discharging Managerial Responsibilities (PDMR) and Persons Closely Associated with them (PCA)

The Company has been notified that:

1. on 24 November 2025, Abicad Holding Limited (Abicad), a PCA of Amit Bhatia, Non-executive Chair of Breedon Group plc (Company) and PDMR, has acquired 200,000 ordinary shares of £0.01 each in the Company (Shares) at the price of 369.6423 pence per Share upon the exercise of the third tranche of the option agreements entered into on 27 November 2024 (and notified to the market on 2 December 2024) (the Option Agreements); and

2. on 25 November 2025, Abicad acquired a further 200,000 Shares at the price of 369.6423 pence per Share upon the exercise of the fourth tranche of the Option Agreements.

Under the Option Agreements the relevant option tranche is automatically exercised and the relevant Shares are acquired if the closing price of a Breedon ordinary share is below or equal to the relevant exercise price for that tranche on the option expiration date.

Following the exercise of the first four tranches of the Option Agreements, Abicad currently holds 66,254,894 Shares, equating to approximately 19.12% of the Company's total issued share capital (at today's date). If all of the Shares are acquired under the remaining tranches of the Option Agreements and Abicad does not dispose of any of its existing interests in the Shares, Abicad would have an aggregate interest in 67,054,894 Shares, equating to approximately 19.35% of the Company's total issued share capital (at today's date).

The acquisitions of the Shares described above, and any potential future acquisitions, represent a continuation of Abicad's previously announced intention to make market purchases of the Shares over time. 

This notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

Enquiries:

 

Breedon Group plc www.breedongroup.com 

James Atherton-Ham, Group General Counsel +44 (0)1332 981215

Louise Turner-Smith, Head of Investor Relations +44 (0)7860 911909

 

MHP (Public Relations Adviser) +44 (0)7770 753 544

Reg Hoare, Rachel Farrington, Charles Hirst breedon@mhpgroup.com

Notification and public disclosure of transactions by persons discharging managerial

responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Abicad Holding Limited, a person closely associated with Amit Bhatia

2

Reason for the notification

a)

Position/status

Non-executive Director and PDMR

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares pursuant to an option to acquire shares from a market counterparty

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.696423 per share

200,000

d)

 

Aggregated information (if any)

 

- Aggregated volume

 

- Price

 

 

 

e)

Date of transaction

2025-11-24

f)

Place of the transaction

Outside a trading venue

 

 

Notification and public disclosure of transactions by persons discharging managerial

responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Abicad Holding Limited, a person closely associated with Amit Bhatia

2

Reason for the notification

a)

Position/status

Non-executive Director and PDMR

b)

Is this an initial notification or an amendment to a prior notification?

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Breedon Group plc

b)

LEI

213800DQGNQE3X76WS92

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of £0.01 each

 

GB00BM8NFJ84

b)

Nature of the transaction

Purchase of Ordinary Shares pursuant to an option to acquire shares from a market counterparty

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£3.696423 per share

200,000

d)

 

Aggregated information (if any)

 

- Aggregated volume

 

- Price

 

 

 

e)

Date of transaction

2025-11-25

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEAFWMEISEFF
Date   Source Headline
31st May 20247:00 amRNSTotal Voting Rights
10th May 20244:20 pmRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20243:06 pmRNSTotal Voting Rights
26th Apr 20243:39 pmRNSDirector/PDMR Shareholding
24th Apr 20244:40 pmRNSResult of AGM
24th Apr 20243:33 pmRNSDirector/PDMR Shareholding
24th Apr 20247:00 amRNSAGM Trading Update
5th Apr 20243:49 pmRNSDirector/PDMR Shareholding
4th Apr 20242:35 pmRNSDirector/PDMR Shareholding
28th Mar 20244:11 pmRNSTotal Voting Rights
18th Mar 202410:00 amRNS2023 Annual Report and Notice of AGM
12th Mar 20243:09 pmRNSApplication for Admission of Consideration Shares
7th Mar 20247:00 amRNSCompletion of Acquisition
6th Mar 20247:00 amRNSAcquisition
6th Mar 20247:00 amRNSFinal Results
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20243:51 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSNotice of Results
31st Jan 20249:18 amRNSTotal Voting Rights
29th Jan 20244:09 pmRNSHolding(s) in Company
29th Dec 20237:00 amRNSBlock listing six monthly return
29th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSNovember Trading Statement
16th Nov 202310:07 amRNSDirector/PDMR Shareholding
8th Nov 20234:01 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
19th Oct 20231:59 pmRNSHolding(s) in Company
9th Oct 20232:24 pmRNSHolding(s) in Company
9th Oct 20232:23 pmRNSDirector/PDMR Shareholding
9th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 202310:53 amRNSDirector/PDMR Shareholding
9th Oct 202310:47 amRNSHolding(s) in Company
6th Oct 20235:15 pmRNSDirector/PDMR Shareholding
5th Oct 20235:32 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSIntention to acquire additional shares of Breedon
3rd Oct 20237:00 amRNSInvestor site visit
2nd Oct 202311:18 amRNSInterim Dividend Timetable
29th Sep 20239:37 amRNSTotal Voting Rights
31st Aug 202310:15 amRNSTotal Voting Rights
30th Aug 20235:02 pmRNSDirector/PDMR Shareholding
31st Jul 202311:36 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSInterim results 2023
3rd Jul 20231:55 pmRNSNotice of Interim Results 2023
30th Jun 20239:55 amRNSTotal Voting Rights
27th Jun 202311:48 amRNSBlock Listing of Ordinary Shares
13th Jun 202310:51 amRNSReduction of Capital Effective
6th Jun 20235:02 pmRNSOutcome of Court Hearing on Reduction of Capital
2nd Jun 20233:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.